[1]
M. Jukić, “Synergy Between Selective Serotonin Reuptake Inhibitors and α2-Adrenergic Receptor Antagonists in the Treatment of Depression: Pharmacological Rationale and Clinical Significance”, engrami, vol. 48, no. 1, Jun. 2026, doi: 10.5937/engrami48-67252.